Short answer · Medically reviewed summary · Last updated: 2026-05-08
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is primarily caused by genetic mutations that disrupt the electrical stability of neurons in the brain's movement centers. While the condition is often hereditary, symptoms are triggered by sudden voluntary movements, representing a complex interplay between a genetic predisposition and environmental physical stimuli. What is the genetic basis of Paroxysmal Kinesigenic Choreathetosis? The most significant breakthrough in understanding Paroxysmal Kinesigenic Choreathetosis is the discovery of mutations in the PRRT2 gene (Proline-Rich Transmembrane Protein 2).
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is primarily caused by genetic mutations that disrupt the electrical stability of neurons in the brain's movement centers. While the condition is often hereditary, symptoms are triggered by sudden voluntary movements, representing a complex interplay between a genetic predisposition and environmental physical stimuli.
The most significant breakthrough in understanding Paroxysmal Kinesigenic Choreathetosis is the discovery of mutations in the PRRT2 gene (Proline-Rich Transmembrane Protein 2). This gene provides instructions for making a protein that regulates neurotransmitter release. When PRRT2 is mutated, the brain’s "brakes" on electrical signaling become less efficient. Approximately 70% to 80% of familial cases of Paroxysmal Kinesigenic Choreathetosis are linked to this specific gene, which follows an autosomal dominant inheritance pattern.
In Paroxysmal Kinesigenic Choreathetosis, the underlying genetic mutation does not cause constant movement problems. Instead, it lowers the threshold for an "electrical storm" in the basal ganglia. Clinical triggers typically include:
While most cases are primary (genetic), secondary Paroxysmal Kinesigenic Choreathetosis can occur due to brain injury or metabolic disturbances. These include:
While the role of PRRT2 is well-established, researchers continue to study why Paroxysmal Kinesigenic Choreathetosis presents with such variable severity even within the same family. Current research is focused on whether modifier genes or environmental factors influence the frequency of these episodes and how the brain compensates for these electrical instabilities over time.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.